CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 165 filers reported holding CLOVIS ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,000 | – | 195 | +282.4% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 51 | -80.6% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 263 | +22.9% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 214 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -75.0% | 214 | -65.4% | 0.00% | – |
| Q3 2020 | $4,000 | -20.0% | 619 | -17.5% | 0.00% | – |
| Q2 2020 | $5,000 | – | 750 | +74900.0% | 0.00% | – |
| Q2 2019 | $0 | – | 1 | -50.0% | 0.00% | – |
| Q1 2019 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 407,416 | $18,097,419,000 | 17.62% |
| Boxer Capital, LLC | 850,000 | $37,757,000 | 14.60% |
| Consonance Capital Management LP | 2,730,887 | $121,306,000 | 13.32% |
| Palo Alto Investors LP | 3,804,088 | $168,978,000 | 9.64% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 298,982 | $13,281,000 | 8.01% |
| Redmile Group, LLC | 1,620,355 | $71,976,000 | 6.20% |
| Crosspoint Capital Strategies, LLC | 84,076 | $3,735,000 | 3.32% |
| Ghost Tree Capital, LLC | 220,000 | $9,772,000 | 2.35% |
| PointState Capital LP | 3,171,978 | $140,899,000 | 2.03% |
| NEA Management Company, LLC | 1,139,890 | $50,634,000 | 2.01% |